Related Experiment Video
Updated: Jan 5, 2026
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.7K
Planning and analyzing clinical trials with competing risks: Recommendations for choosing appropriate statistical
J C Poythress1, Misun Yu Lee2, James Young2
1Department of Statistics, University of Georgia, Athens, Georgia.
Pharmaceutical Statistics
|October 19, 2019
Summary
Ignoring competing risks in time-to-event data analysis can bias results. Use Gray's test and appropriate models like cause-specific hazards (CSH) or Fine-Gray (F-G) with diagnostics for valid inference.
Area of Science:
- Biostatistics
- Survival Analysis
- Epidemiology
Background:
- Competing risks in time-to-event data arise when multiple event types can occur.
- Ignoring these risks leads to biased statistical inference for the event of interest.
- Accurate analysis requires methods that formally account for competing risks.
Purpose of the Study:
- To review bias mechanisms in competing risks analysis.
- To describe statistical methods for unbiased inference.
- To compare semiparametric models and diagnostic procedures.
Main Methods:
- Simulation studies to compare statistical tests and models.
- Review of bias mechanisms and interpretation of model estimates.
- Evaluation of model diagnostic methods for cause-specific hazards (CSH) and Fine-Gray (F-G) models.
Main Results:
- Gray's test is recommended over the logrank test for nonparametric hypothesis testing.
- Differences in estimates between CSH and F-G models are identified.
- Model fit diagnostics are crucial for valid statistical inference.
Conclusions:
- Proper accounting for competing risks is essential for accurate time-to-event data analysis.
- Analysts should use Gray's test and consider CSH/F-G models with diagnostics.
- Model diagnostics significantly impact the validity of statistical inference in competing risks settings.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
373
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
373
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:12Hazard Ratio
541
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
541
01:20Comparing the Survival Analysis of Two or More Groups
524
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
524
01:25Strategies for Assessing and Addressing Confounding
332
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
332
01:12Statistical Software for Data Analysis and Clinical Trials
1.3K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.3K